A staged pipeline designed to prove the platform with a focused lead program, then expand into adjacent high-value regenerative markets.
Bioresorbable bone fixation — silk-based screws and plates for fracture fixation. Verified through mechanical, biological, and animal studies.
Explore the lead programPorous tissue-engineering scaffolds for soft- and hard-tissue regeneration, with tunable architecture and resorption — building on silk scaffolds the founder has already fabricated.
Explore SilkMatrix ScaffoldAdvanced wound-healing matrices — the same silk scaffold technology, adapted into bioactive, breathable dressings for tissue repair.
Explore SilkMatrix WoundGuided bone regeneration membranes for dental and maxillofacial procedures — resorbable, cell-friendly barrier membranes.
Bioactive silk coatings for orthopaedic and dental implants to improve integration and surface biology.
Silk carriers for controlled local release — a longer-horizon opportunity enabled by the same material science.
Maturity reflects current development stage. The lead fixation program is prioritised for the two-phase plan; other lines advance as the platform is validated.
The lead program is chosen to maximise scientific credibility and the clearest path to a regulated, reimbursable device.
A load-bearing implant validated through mechanical and animal testing proves the platform’s most demanding capability.
Orthopaedic fixation is a large, well-defined market with established clinical and reimbursement pathways.
Success de-risks every adjacent line — dental, wound, scaffolds and coatings all inherit the validated science.
See the full development and validation roadmap for our bioresorbable bone fixation system.